Entyvio lengthen dose-interval study: Lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease

Webber Chan^*, Nicole Lynch, Peter Bampton, Jeff Chang, Alvin Chung, Timothy Florin, David J. Hetzel, Simon Jakobovits, Gregory Moore, Paul Pavli, Graham Radford-Smith, Lena Thin, Brandon Baraty, Craig Haifer, Yunki Yau, Rupert W.L. Leong